APM
PRVL

Avidity Partners Management’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Avidity Partners Management’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,028,800
Closed -$15.3M – 97
2020
Q2 		$15.3M Buy
+1,028,800
New +$15.3M 0.98% 40